Monoclonal gammopathy of undetermined significance and multiple myeloma

被引：2
|
作者：
Schmalzing, M. [1 ]
Tony, H. -P. [1 ]
Knop, S. [1 ]
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2017年 / 76卷
关键词：
RHEUMATOID-ARTHRITIS; PSORIATIC PATIENTS; THERAPY; DEXAMETHASONE; RISK;
D O I：
10.1007/s00393-017-0335-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In rheumatological practice monoclonal gammopathy of undetermined significance (MGUS) is a common incidental finding. Several rheumatic inflammatory diseases are known to have an elevated risk of MGUS, which can evolve into multiple myeloma or other lymphatic malignancies. The relevant definitions of disease entities are described, as well as algorithms for further diagnostic work-up and follow-up for monoclonal gammopathy, depending on the risk of progression. Therapeutic strategies against multiple myeloma are presented. Some of these therapeutic modalities could play a future role in treating plasma cell-dominated autoimmune diseases.
引用
收藏
页码：33 / 37
页数：5
相关论文
共 50 条
  • [1] Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    JAMA ONCOLOGY, 2015, 1 (02) : 174 - 175
  • [2] Monoclonal Gammopathy of undetermined significance and smoldering multiple myeloma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (06) : 1093 - +
  • [3] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Robert A. Kyle
    S. Vincent Rajkumar
    Current Hematologic Malignancy Reports, 2010, 5 : 62 - 69
  • [4] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Kyle, Robert A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Rajkumar, S. Vincent
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 775 - +
  • [5] Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance
    Bladé J.
    Rosiñol L.
    Current Treatment Options in Oncology, 2006, 7 (3) : 237 - 245
  • [6] Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance
    Piechotta, Vanessa
    Skoetz, Nicole
    Engelhardt, Monika
    Einsele, Hermann
    Goldschmidt, Hartmut
    Scheid, Christof
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (14): : 253 - +
  • [7] Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis
    Bouvard, Beatrice
    Royer, Mathieu
    Chappard, Daniel
    Audran, Maurice
    Hoppe, Emmanuel
    Legrand, Erick
    JOINT BONE SPINE, 2010, 77 (02) : 120 - 124
  • [8] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 62 - 69
  • [9] Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Kyle, Robert A.
    BLOOD REVIEWS, 2007, 21 (05) : 255 - 265
  • [10] Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults
    Guerard, Emily J.
    Tuchman, Sascha A.
    CLINICS IN GERIATRIC MEDICINE, 2016, 32 (01) : 191 - +
12345